EcoDrugPlus

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSG00000168959
Gene: GRM5
Gene Synonyms: GPRC1E,MGLU5,MGLUR5,PPP1R86
9 APIs:
9 Enzyme and pathways 7 Cross references
278 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutathione S-Transferase Pi 1

Ensembl ID : ENSG00000084207
Gene: GSTP1
Gene Synonyms: FAEES3,GST3,GSTP
1 APIs:
13 Enzyme and pathways 8 Cross references
172 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSG00000105723
Gene: GSK3A
Gene Synonyms:
4 APIs:
25 Enzyme and pathways 7 Cross references
259 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSG00000082701
Gene: GSK3B
Gene Synonyms:
6 APIs:
64 Enzyme and pathways 7 Cross references
244 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glycoprotein Vi Platelet

Ensembl ID : ENSG00000088053
Gene: GP6
Gene Synonyms: GPVI
1 APIs:
5 Enzyme and pathways 9 Cross references
139 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSG00000109163
Gene: GNRHR
Gene Synonyms: GRHR,LHRHR
23 APIs:
7 Enzyme and pathways 8 Cross references
242 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSG00000106128
Gene: GHRHR
Gene Synonyms:
2 APIs:
7 Enzyme and pathways 8 Cross references
193 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSG00000121853
Gene: GHSR
Gene Synonyms:
10 APIs:
7 Enzyme and pathways 8 Cross references
211 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSG00000164116
Gene: GUCY1A1
Gene Synonyms: GC-SA3,GUC1A3,GUCY1A3
13 APIs:
5 Enzyme and pathways 8 Cross references
203 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSG00000152402
Gene: GUCY1A2
Gene Synonyms: GC-SA2,GUC1A2
13 APIs:
5 Enzyme and pathways 7 Cross references
203 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSG00000061918
Gene: GUCY1B1
Gene Synonyms: GC-S-BETA-1,GC-SB3,GUC1B3,GUCY1B3
13 APIs:
5 Enzyme and pathways 7 Cross references
211 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSG00000080824
Gene: HSP90AA1
Gene Synonyms: FLJ31884,HSP89,HSP90,HSP90N,HSPC1,HSPCA
9 APIs:
109 Enzyme and pathways 7 Cross references
263 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).